These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21715171)
21. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018 [TBL] [Abstract][Full Text] [Related]
22. Clinical trials with immunotherapy for high-grade glioma. Ruzevick J; Jackson C; Phallen J; Lim M Neurosurg Clin N Am; 2012 Jul; 23(3):459-70. PubMed ID: 22748658 [TBL] [Abstract][Full Text] [Related]
23. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial. Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029 [TBL] [Abstract][Full Text] [Related]
25. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Prins RM; Wang X; Soto H; Young E; Lisiero DN; Fong B; Everson R; Yong WH; Lai A; Li G; Cloughesy TF; Liau LM J Immunother; 2013 Feb; 36(2):152-7. PubMed ID: 23377664 [TBL] [Abstract][Full Text] [Related]
26. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses. Homma S; Sagawa Y; Ito M; Ohno T; Toda G Clin Exp Immunol; 2006 Apr; 144(1):41-7. PubMed ID: 16542363 [TBL] [Abstract][Full Text] [Related]
28. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination. Liu G; Black KL; Yu JS Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423 [TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA. Zhang Z; Tang LL; Zhan RY; Tong Y; Yao HP; Du LA J Zhejiang Univ Sci; 2004 Oct; 5(10):1298-303. PubMed ID: 15362204 [TBL] [Abstract][Full Text] [Related]
30. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Wheeler CJ; Das A; Liu G; Yu JS; Black KL Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167 [TBL] [Abstract][Full Text] [Related]
31. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response. Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases]. Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087 [TBL] [Abstract][Full Text] [Related]
33. Vaccines for glioblastoma and high-grade glioma. Wheeler CJ; Black KL Expert Rev Vaccines; 2011 Jun; 10(6):875-86. PubMed ID: 21692706 [TBL] [Abstract][Full Text] [Related]